| 763298 |
CANCER MANAGEMENT AND RESEARCH |
Characterization of Treatments and Disease Course for Women with Breast Cancer Brain Metastases: 5-Year Retrospective Single Institution Experience |
2021-11-01 |
10.2147/cmar.s330829 |
Chew Sonya, Carroll Hailey Kathryn, Darwish Waseem, Boychak Oleksandr, Higgins Michaela, McCaffrey John, Kelly Catherine Margaret |
| 763297 |
CANCER MANAGEMENT AND RESEARCH |
Microribonucleic Acid-15a-5p Alters Adriamycin Resistance in Breast Cancer Cells by Targeting Cell Division Cycle-Associated Protein 4 |
2021-11-01 |
10.2147/cmar.s333830 |
Zhang Jiang-Tao, Chen Jun, Ruan Hui-Chao, Li Feng-Xi, Pang Sen, Xu Yu-Ju, Huang Dao-Lai, Wu Xiang-Hua |
| 763296 |
CANCER MANAGEMENT AND RESEARCH |
Knockdown of hsa_circ_0000729 Inhibits the Tumorigenesis of Non-Small Cell Lung Cancer Through Mediation of miR-1281/FOXO3 Axis |
2021-11-01 |
10.2147/cmar.s318980 |
Xie Xiao, Ding Fangbao, Xiao Haibo |
| 763295 |
CANCER MANAGEMENT AND RESEARCH |
A Novel Circular RNA circPTCD3 Promotes Breast Cancer Progression Through Sponging miR-198 |
2021-11-01 |
10.2147/cmar.s256091 |
Zhang Zhaohui, Hu Hao, Li Qian, Yi Fumei, Liu Yan'e |
| 763294 |
CANCER MANAGEMENT AND RESEARCH |
Cost-Effectiveness Analysis of Gefitinib Plus Chemotherapy versus Gefitinib Alone for Advanced Non-Small-Cell Lung Cancer with EGFR Mutations in China |
2021-11-01 |
10.2147/cmar.s334643 |
Shu Yamin, Zhang Qilin, He Xucheng, Chen Li |
| 763293 |
CANCER MANAGEMENT AND RESEARCH |
Checkpoint Inhibitors in Melanoma Patients with Underlying Autoimmune Disease |
2021-11-01 |
10.2147/cmar.s283217 |
Dietz Hilary, Weinmann Sophia C, Salama April K |
| 763292 |
CANCER MANAGEMENT AND RESEARCH |
Circulating miRNAs as Potential Biomarkers in Prostate Cancer Patients Undergoing Radiotherapy |
2021-11-01 |
10.2147/cmar.s325246 |
Kachris Stefanos, Papadaki Chara, Rounis Konstantinos, Tsitoura Eliza, Kokkinaki Chrysanthi, Nikolaou Christoforos, Sourvinos George, Mavroudis Dimitrios |
| 763291 |
CANCER MANAGEMENT AND RESEARCH |
Sp1 Contributes to Radioresistance of Cervical Cancer Through Targeting G2/M Cell Cycle Checkpoint CDK1 [Corrigendum] |
2021-11-01 |
10.2147/cmar.s348374 |
Deng Yuan-Run, Chen Xiao-Jing, Chen Wei, Wu Lan-Fang, Jiang Hui-Ping, Lin Dan, Wang Li-Jing, Wang Wei, Guo Sui-Qun |
| 763290 |
CANCER MANAGEMENT AND RESEARCH |
Bioinformatics Analysis of Hub Genes and Potential Therapeutic Agents Associated with Gastric Cancer |
2021-11-01 |
10.2147/cmar.s341485 |
Zhang Shiyu, Xiang Xuelian, Liu Li, Yang Huiying, Cen Dongliang, Tang Guodu |
| 763289 |
CANCER MANAGEMENT AND RESEARCH |
Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience |
2021-11-01 |
10.2147/cmar.s321202 |
Schaefer Andrew, Huang Ying, Kittai Adam, Maakaron Joseph E, Saygin Caner, Brammer Jonathan, Penza Sam, Saad Ayman, Jaglowski Samantha M, William Basem M |
